T1/T2 ratio: A quantitative sensitive marker of brain tissue integrity in multiple sclerosis.


Journal

Journal of neuroimaging : official journal of the American Society of Neuroimaging
ISSN: 1552-6569
Titre abrégé: J Neuroimaging
Pays: United States
ID NLM: 9102705

Informations de publication

Date de publication:
Mar 2022
Historique:
revised: 30 09 2021
received: 28 07 2021
accepted: 14 10 2021
pubmed: 10 11 2021
medline: 22 3 2022
entrez: 9 11 2021
Statut: ppublish

Résumé

The aim of this study is to determine whether cerebral white matter (WM) microstructural damage, defined by decreased fractional anisotropy (FA) and increased axial (AD) and radial (RD) diffusivities, could be detected as accurately by measuring the T1/T2 ratio, in relapsing-remitting multiple sclerosis (RRMS) patients compared to healthy control (HC) subjects. Twenty-eight RRMS patients and 24 HC subjects were included in this study. Region-based analysis based on the ICBM-81 diffusion tensor imaging (DTI) atlas WM labels was performed to compare T1/T2 ratio to DTI values in normal-appearing WM (NAWM) regions of interest. Lesions segmentation was also performed and compared to the HC global WM. A significant 19.65% decrease of T1/T2 ratio values was observed in NAWM regions of RRMS patients compared to HC. A significant 6.30% decrease of FA, as well as significant 4.76% and 10.27% increases of AD and RD, respectively, were observed in RRMS compared to the HC group in various NAWM regions. Compared to the global WM HC mask, lesions have significantly decreased T1/T2 ratio and FA and increased AD and RD (p < . 001). Results showed significant differences between RRMS and HC in both DTI and T1/T2 ratio measurements. T1/T2 ratio even demonstrated extensive WM abnormalities when compared to DTI, thereby highlighting the ratio's sensitivity to subtle differences in cerebral WM structural integrity using only conventional MRI sequences.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
The aim of this study is to determine whether cerebral white matter (WM) microstructural damage, defined by decreased fractional anisotropy (FA) and increased axial (AD) and radial (RD) diffusivities, could be detected as accurately by measuring the T1/T2 ratio, in relapsing-remitting multiple sclerosis (RRMS) patients compared to healthy control (HC) subjects.
METHODS METHODS
Twenty-eight RRMS patients and 24 HC subjects were included in this study. Region-based analysis based on the ICBM-81 diffusion tensor imaging (DTI) atlas WM labels was performed to compare T1/T2 ratio to DTI values in normal-appearing WM (NAWM) regions of interest. Lesions segmentation was also performed and compared to the HC global WM.
RESULTS RESULTS
A significant 19.65% decrease of T1/T2 ratio values was observed in NAWM regions of RRMS patients compared to HC. A significant 6.30% decrease of FA, as well as significant 4.76% and 10.27% increases of AD and RD, respectively, were observed in RRMS compared to the HC group in various NAWM regions. Compared to the global WM HC mask, lesions have significantly decreased T1/T2 ratio and FA and increased AD and RD (p < . 001).
CONCLUSIONS CONCLUSIONS
Results showed significant differences between RRMS and HC in both DTI and T1/T2 ratio measurements. T1/T2 ratio even demonstrated extensive WM abnormalities when compared to DTI, thereby highlighting the ratio's sensitivity to subtle differences in cerebral WM structural integrity using only conventional MRI sequences.

Identifiants

pubmed: 34752685
doi: 10.1111/jon.12943
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

328-336

Informations de copyright

© 2021 American Society of Neuroimaging.

Références

Filippi M, Rocca MA. Novel MRI approaches to assess patients with multiple sclerosis. Curr Opin Neurol 2010;23:212-7.
Rovira À., Auger C. Beyond McDonald: updated perspectives on MRI diagnosis of multiple sclerosis. Expert Review of Neurotherapeutics 2021;21(8):895-911. https://doi.org/10.1080/14737175.2021.1957832
Moll NM, Rietsch AM, Thomas S, Ransohoff AJ, Lee JC, Fox R, et al. Multiple sclerosis normal-appearing white matter: pathology-imaging correlations. Ann Neurol 2011;70:764-73.
Ganzetti M, Wenderoth N, Mantini D. Whole brain myelin mapping using T1- and T2-weighted MR imaging data. Front Hum Neurosci 2014;8:671.
Iwatani J, Ishida T, Donishi T, Ukai S, Shinosaki K, Terada M, et al. Use of T1-weighted/T2-weighted magnetic resonance ratio images to elucidate changes in the schizophrenic brain. Brain Behav 2015;5:e00399.
Uddin MN, Figley TD, Solar KG, Shatil AS, Figley CR. Comparisons between multi-component myelin water fraction, T1w/T2w ratio, and diffusion tensor imaging measures in healthy human brain structures. Sci Rep 2019;9:2500.
Glasser MF, Van Essen DC. Mapping human cortical areas in vivo based on myelin content as revealed by T1- and T2-weighted MRI. J Neurosci 2011;31:11597-616.
Pareto D, Garcia-Vidal A, Alberich M, Auger C, Montalban X, Tintoré M, et al. Ratio of T1-weighted to T2-weighted signal intensity as a measure of tissue integrity: comparison with magnetization transfer ratio in patients with multiple sclerosis. AJNR Am J Neuroradiol 2020;41:461-3.
Hagiwara A, Hori M, Kamagata K, Warntjes M, Matsuyoshi D, Nakazawa M, et al. Myelin measurement: comparison between simultaneous tissue relaxometry, magnetization transfer saturation index, and T1w/T2w ratio methods. Sci Rep 2018;8:10554.
Cotton F, Kremer S, Hannoun S, Vukusic S, Dousset V. OFSEP, a nationwide cohort of people with multiple sclerosis: consensus minimal MRI protocol. J Neuroradiol 2015;42:133-40.
Rovira À, Wattjes MP, Tintoré M, Tur C, Yousry TA, Sormani MP, et al. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process. Nat Rev Neurol 2015;11:471-82.
Righart R, Biberacher V, Jonkman LE, Klaver R, Schmidt P, Buck D, et al. Cortical pathology in multiple sclerosis detected by the T1/T2-weighted ratio from routine magnetic resonance imaging. Ann Neurol 2017;82:519-29.
Yousuf F, Kim G, Tauhid S, Glanz BI, Chu R, Tummala S, et al. The contribution of cortical lesions to a composite MRI scale of disease severity in multiple sclerosis. Front Neurol 2016;7:99.
Bakshi R, Neema M, Tauhid S, Healy BC, Glanz BI, Kim G, et al. An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2. Neuroreport 2014;25:1156-61.
Kim G, Tauhid S, Dupuy SL, Tummala S, Khalid F, Healy BC, et al. An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis. J Neurol 2016;263:531-8.
Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 2005;58:840-6.
Jain S, Sima DM, Ribbens A, Cambron M, Maertens A, Van Hecke W, et al. Automatic segmentation and volumetry of multiple sclerosis brain lesions from MR images. Neuroimage Clin 2015;8:367-75.
Avants BB, Tustison NJ, Song G, Cook PA, Klein A, Gee JC. A reproducible evaluation of ANTs similarity metric performance in brain image registration. Neuroimage 2011;54:2033-44.
Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TEJ, Johansen-Berg H, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(Suppl 1):S208-19.
Team RC. R: A language and environment for statistical computing. http://www.r-project.org/. Accessed September, 09 2019.
Assaf Y, Pasternak O. Diffusion tensor imaging (DTI)-based white matter mapping in brain research: a review. J Mol Neurosci 2008;34:51-61.
Cooper G, Finke C, Chien C, Brandt AU, Asseyer S, Ruprecht K, et al. Standardization of T1w/T2w ratio improves detection of tissue damage in multiple sclerosis. Front Neurol 2019;10:334.
Beer A, Biberacher V, Schmidt P, Righart R, Buck D, Berthele A, et al. Tissue damage within normal appearing white matter in early multiple sclerosis: assessment by the ratio of T1- and T2-weighted MR image intensity. J Neurol 2016;263:1495-502.
Hannoun S, Bagory M, Durand-Dubief F, Ibarrola D, Comte JC, Confavreux C, et al. Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis. PLoS One 2012;7:e32525.
Liu Z, Pardini M, Yaldizli Ö, Sethi V, Muhlert N, Wheeler-Kingshott CAM, et al. Magnetization transfer ratio measures in normal-appearing white matter show periventricular gradient abnormalities in multiple sclerosis. Brain 2015;138:1239-46.
Heath F, Hurley SA, Johansen-Berg H, Sampaio-Baptista C. Advances in noninvasive myelin imaging. Dev Neurobiol 2018;78:136-51.
Harel A, Sperling D, Petracca M, Ntranos A, Katz-Sand I, Krieger S, Lublin F, Wang Z, Liu Y, Inglese M. Brain microstructural injury occurs in patients with RRMS despite ‘no evidence of disease activity’. Journal of Neurology, Neurosurgery & Psychiatry 2018;89(9):977-982. https://doi.org/10.1136/jnnp-2017-317606
Saccenti L, Hagiwara A, Andica C, Yokoyama K, Fujita S, Kato S, et al. Myelin measurement using quantitative magnetic resonance imaging: a correlation study comparing various imaging techniques in patients with multiple sclerosis. Cells 2020;9:393.
Laule C, Moore GRW. Myelin water imaging to detect demyelination and remyelination and its validation in pathology. Brain Pathol 2018;28:750-64.
Uddin MN, Figley TD, Marrie RA, Figley CR. Can T 1 w/T 2 w ratio be used as a myelin-specific measure in subcortical structures? Comparisons between FSE-based T 1 w/T 2 w ratios, GRASE-based T 1 w/T 2 w ratios and multi-echo GRASE-based myelin water fractions. NMR in Biomedicine 2018;31(3):e3868. https://doi.org/10.1002/nbm.3868
Arshad M, Stanley JA, Raz N. Test-retest reliability and concurrent validity of in vivo myelin content indices: Myelin water fraction and calibrated T1 w/T2 w image ratio. Human Brain Mapping 2017;38(4):1780-1790. https://doi.org/10.1002/hbm.23481
Hannoun S, Kocevar G, Durand-Dubief F, Stamile C, Naji A, Cotton F, et al. Evidence of axonal damage in cerebellar peduncles without T2-lesions in multiple sclerosis. Eur J Radiol 2018;108:114-9.
Uddin MN, Figley TD, Figley CR. Effect of echo time and T(2)-weighting on GRASE-based T(1)w/T(2)w ratio measurements at 3T. Magn Reson Imaging 2018;51:35-43.
Lee K, Cherel M, Budin F, Gilmore J, Zaldarriaga Consing K, Rasmussen J, et al. Early postnatal myelin content estimate of white matter via T1w/T2w ratio. In Gimi B, Molthen RC, editors. Medical imaging 2015: biomedical applications in molecular, structural, and functional imaging. 9417: SPIE; 2015.
Ganzetti M, Wenderoth N, Mantini D. Mapping pathological changes in brain structure by combining T1- and T2-weighted MR imaging data. Neuroradiology 2015;57:917-28.
Pelkmans W, Dicks E, Barkhof F, Vrenken H, Scheltens P, Flier WM, et al. Gray matter T1-w/T2-w ratios are higher in Alzheimer's disease. Hum Brain Mapp 2019;40:3900-09.
Ishida T, Donishi T, Iwatani J, Yamada S, Takahashi S, Ukai S, et al. Elucidating the aberrant brain regions in bipolar disorder using T1-weighted/T2-weighted magnetic resonance ratio images. Psychiatry Res Neuroimaging 2017;263:76-84.
Yasuno F, Kazui H, Morita N, Kajimoto K, Ihara M, Taguchi A, Yamamoto A, Matsuoka K, Takahashi M, Nakagawara J, Iida H, Kishimoto T, Nagatsuka K. Use of T1-weighted/T2-weighted magnetic resonance ratio to elucidate changes due to amyloid β accumulation in cognitively normal subjects. NeuroImage: Clinical 2017;13:209-214. https://doi.org/10.1016/j.nicl.2016.11.029
Nakamura K, Chen JT, Ontaneda D, Fox RJ, Trapp BD. T1-/T2-weighted ratio differs in demyelinated cortex in multiple sclerosis. Ann Neurol 2017;82:635-9.

Auteurs

Salem Hannoun (S)

Medical Imaging Sciences Program, Division of Health Professions, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon.

Gabriel Kocevar (G)

CREATIS, UMR 5220 CNRS & U1294 INSERM, Université Claude Bernard - Lyon1, Université de Lyon, Villeurbanne, France.
Seenovate, Datascience pole, Lyon, France.

Pekes Codjia (P)

CREATIS, UMR 5220 CNRS & U1294 INSERM, Université Claude Bernard - Lyon1, Université de Lyon, Villeurbanne, France.
Service de Radiologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Bénite, France.

Berardino Barile (B)

CREATIS, UMR 5220 CNRS & U1294 INSERM, Université Claude Bernard - Lyon1, Université de Lyon, Villeurbanne, France.

Francois Cotton (F)

CREATIS, UMR 5220 CNRS & U1294 INSERM, Université Claude Bernard - Lyon1, Université de Lyon, Villeurbanne, France.
Service de Radiologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Bénite, France.

Francoise Durand-Dubief (F)

CREATIS, UMR 5220 CNRS & U1294 INSERM, Université Claude Bernard - Lyon1, Université de Lyon, Villeurbanne, France.
Service de Neurologie A, Hôpital Neurologique Pierre Wertheimer, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France.

Dominique Sappey-Marinier (D)

CREATIS, UMR 5220 CNRS & U1294 INSERM, Université Claude Bernard - Lyon1, Université de Lyon, Villeurbanne, France.
Département IRM, CERMEP-Imagerie du Vivant, Université de Lyon, Bron, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH